Patents Assigned to ISIS Pharmaceticals, Inc.
  • Patent number: 6358932
    Abstract: Oligonucleotides are provided which are targeted to nucleic acids encoding human c-raf and capable of inhibiting raf expression. The oligonucleotides contain a methoxyethoxy (2′—O—CH2CH2OCH3) modification at the 2′ position of at least one nucleotide. Methods of inhibiting the expression of human raf using oligonucleotides of the invention are also provided. The present invention further comprises methods of inhibiting hyperproliferation of cells and methods of treating abnormal proliferative conditions which employ oligonucleotides of the invention.
    Type: Grant
    Filed: February 18, 2000
    Date of Patent: March 19, 2002
    Assignee: ISIS Pharmaceticals, Inc.
    Inventor: Brett P. Monia